PepTiDa is an innovative biotech startup and spin-off from the University of Milan developing peptide-based and peptidomimetic approaches for severe brain diseases.

The company focuses on neuroprotection, synaptic dysfunction and neurodegeneration, integrating neuroscience, peptide design, target biology and translational development. Its lead program, SIMBA2, is a peptide-based candidate in preclinical development targeting JNK3, a key molecular pathway involved in neuronal damage.

PepTiDa’s approach combines strong scientific foundations with a data-driven and AI-enabled execution model, aiming to build robust preclinical evidence, clear regulatory pathways and partnership-ready therapeutic assets.

The company is open to scientific collaborations, investors and industrial partnerships focused on the development of new peptide-based therapies for brain diseases.

PepTiDa

Org chart

Teams

Offices

PepTiDa

Org chart

Teams

Offices

Related companies